Welcome to Paid Research Studies




  • Conditions:   Multiple Sclerosis;   Progressive Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Primary Progressive Multiple Sclerosis
    Intervention:   Drug: Alpha Lipoic Acid
    Sponsor:   Rebecca Spain
    Recruiting

  • Condition:   Cystinuria
    Interventions:   Dietary Supplement: Alpha lipoic acid;   Drug: Placebo
    Sponsors:   University of California, San Francisco;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting

  • Condition:   Hypertension
    Interventions:   Dietary Supplement: Oral Antioxidant;   Other: Exercise rehabilitation
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Hepatosplenic T-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   T-cell Adult Acute Lymphoblastic Leukemia;   T-cell Large Granular Lymphocyte Leukemia
    Interventions:   Drug: 6,8-bis(benzylthio)octanoic acid;   Drug: bendamustine hydrochloride
    Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Multiple Sclerosis
    Interventions:   Drug: Lipoic acid;   Drug: Placebo
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Condition:   Mental Health Disorders
    Interventions:   Dietary Supplement: PTSD/GAD Antioxidant;   Dietary Supplement: PTSD/GAD Placebo;   Dietary Supplement: Healthy Control Antioxidant;   Dietary Supplement: Healthy Control Placebo
    Sponsor:   Virginia Commonwealth University
    Recruiting

  • Conditions:   Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Recurrent Colon Cancer;   Recurrent Rectal Cancer;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Stage IIIA Colon Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Rectal Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer
    Interventions:   Drug: 6,8-bis(benzylthio)octanoic acid;   Drug: fluorouracil;   Other: pharmacological study;   Other: laboratory biomarker analysis
    Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Heart Failure With Reduced Ejection Fraction
    Interventions:   Dietary Supplement: Antioxidant;   Dietary Supplement: Tetrahydrobiopterin (BH4);   Other: Exercise training
    Sponsors:   VA Office of Research and Development;   University of Utah
    Recruiting

  • Condition:   Diabetes Mellitus, Type 1
    Interventions:   Dietary Supplement: Antioxidant Cocktail;   Dietary Supplement: Resveratrol;   Other: Placebo
    Sponsors:   Augusta University;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting

  • Condition:   Center-involved Diabetic Macular Edema (CI-DME)
    Interventions:   Dietary Supplement: Diabetes Visual Function Study (DiVFuSS) softgels;   Other: canola oil placebo softgels, 2 per day
    Sponsors:   ZeaVision, LLC;   Sound Retina
    Not yet recruiting

  • Conditions:   Mucopolysaccharidosis Disorders;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Alpha-Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Glycoprotein Metabolic Disorders;   Sphingolipidoses;   Recessive Leukodystrophies;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann-Pick B;   Niemann-Pick C Subtype 2;   Sphingomyelin Deficiency;   Peroxisomal Disorders;   Adrenoleukodystrophy With Cerebral Involvement;   Zellweger Syndrome;   Neonatal Adrenoleukodystrophy;   Infantile Refsum Disease;   Acyl-CoA Oxidase Deficiency;   D-Bifunctional Enzyme Deficiency;   Multifunctional Enzyme Deficiency;   Alpha-methylacyl-CoA Racmase Deficiency;   Mitochondrial Neurogastrointestingal Encephalopathy;   Severe Osteopetrosis;   Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation);   Inherited Metabolic Disorders
    Interventions:   Biological: Stem Cell Transplantation;   Drug: IMD Preparative Regimen;   Drug: Osteopetrosis Only Preparative Regimen;   Drug: Osteopetrosis Haploidentical Only Preparative Regimen;   Drug: cALD SR-A (Standard-Risk, Regimen A);   Drug: cALD SR-B (Standard-Risk, Regimen B);   Drug: cALD HR-D (High-Risk, Regimen C);   Drug: cALD HR-D (High-Risk, Regimen D)
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting